Literature DB >> 28370480

POP1 might be recruiting its type-Ia interface for NLRP3-mediated PYD-PYD interaction: Insights from MD simulation.

Jitendra Maharana1, Ashutosh Vats2, Santwana Gautam1, Bibhu Prasad Nayak1, Sushil Kumar2, Jasobanta Sendha1, Sachinandan De2.   

Abstract

Inflammasomes are multiprotein caspase-activating complexes that enhance the maturation and release of proinflammatory cytokines (IL-1β and IL-18) in response to the invading pathogen and/or host-derived cellular stress. These are assembled by the sensory proteins (viz NLRC4, NLRP1, NLRP3, and AIM-2), adaptor protein (ASC), and effector molecule procaspase-1. In NLRP3-mediated inflammasome activation, ASC acts as a mediator between NLRP3 and procaspase-1 for the transmission of signals. A series of homotypic protein-protein interactions (NLRP3PYD :ASCPYD and ASCCARD :CASP1CARD ) propagates the downstream signaling for the production of proinflammatory cytokines. Pyrin-only protein 1 (POP1) is known to act as the regulator of inflammasome. It modulates the ASC-mediated inflammasome assembly by interacting with pyrin domain (PYD) of ASC. However, despite similar electrostatic surface potential, the interaction of POP1 with NLRP3PYD is obscured till date. Herein, to explore the possible PYD-PYD interactions between NLRP3PYD and POP1, a combined approach of protein-protein docking and molecular dynamics simulation was adapted. The current study revealed that POP1's type-Ia interface and type-Ib interface of NLRP3PYD might be crucial for 1:1 PYD-PYD interaction. In addition to type-I mode of interaction, we also observed type-II and type-III interaction modes in two different dynamically stable heterotrimeric complexes (POP1-NLRP3-NLRP3 and POP1-NLRP3-POP1). The inter-residual/atomic distance calculation exposed several critical residues that possibly govern the said interaction, which need further investigation. Overall, the findings of this study will shed new light on hitherto concealed molecular mechanisms underlying NLRP3-mediated inflammasome, which will have strong future therapeutic implications.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  NLRP3; POP1; PYD-PYD interaction; inflammasome; molecular dynamics simulation

Mesh:

Substances:

Year:  2017        PMID: 28370480     DOI: 10.1002/jmr.2632

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  7 in total

1.  In silico characterization and differential expression analysis of 1-deoxy-d-xylulose-5-phosphate reductoisomerase (DXR) of Centella asiatica.

Authors:  Richa Sharma; Kamalakshi Devi; Mahendra K Modi; Priyabrata Sen
Journal:  3 Biotech       Date:  2021-03-22       Impact factor: 2.406

2.  Deciphering the ATP-binding mechanism(s) in NLRP-NACHT 3D models using structural bioinformatics approaches.

Authors:  Jitendra Maharana; Debashis Panda; Sachinandan De
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

Review 3.  NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis.

Authors:  Yang Liu; Chao Li; Honglin Yin; Xinrong Zhang; Yunlun Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-03-31       Impact factor: 2.629

Review 4.  ATP-Binding and Hydrolysis in Inflammasome Activation.

Authors:  Christina F Sandall; Bjoern K Ziehr; Justin A MacDonald
Journal:  Molecules       Date:  2020-10-07       Impact factor: 4.411

5.  Identification of NLRP3PYD Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity.

Authors:  Soroush Moasses Ghafary; Paula M Soriano-Teruel; Shima Lotfollahzadeh; Mónica Sancho; Eva Serrano-Candelas; Fatemeh Karami; Stephen J Barigye; Iván Fernández-Pérez; Rafael Gozalbes; Maryam Nikkhah; Mar Orzáez; Saman Hosseinkhani
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

6.  Clinical significance for diagnosis and prognosis of POP1 and its potential role in breast cancer: a comprehensive analysis based on multiple databases.

Authors:  Xiao He; Ji Wang; Honghao Yu; Wenchang Lv; Yichen Wang; Qi Zhang; Zeming Liu; Yiping Wu
Journal:  Aging (Albany NY)       Date:  2022-09-09       Impact factor: 5.955

7.  The Shigella Type III Secretion Effector IpaH4.5 Targets NLRP3 to Activate Inflammasome Signaling.

Authors:  Xiaolin Wang; Jin Sun; Luming Wan; Xiaopan Yang; Haotian Lin; Yanhong Zhang; Xiang He; Hui Zhong; Kai Guan; Min Min; Zhenxue Sun; Xiaoli Yang; Bin Wang; Mingxin Dong; Congwen Wei
Journal:  Front Cell Infect Microbiol       Date:  2020-09-30       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.